Three-dimensional filamentous human diseased cardiac tissue model

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Stem Cell Biology

Background:

• Cardiac arrhythmias, like Long QT Syndrome type 3 (LQT3), pose significant health risks.
• Current in vitro models often lack the complexity to fully replicate human cardiac tissue.
• Developing advanced models is crucial for understanding disease mechanisms and drug efficacy.

Purpose of the Study:

• To create a sophisticated 3D human cardiac tissue model.
• To investigate the electrophysiological and contractility defects in LQT3 using patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs).
• To assess drug responses and cardiotoxicity in this advanced in vitro model.

Main Methods:

• Populating synthetic filamentous matrices with wild-type (WT) and LQT3 iPS-CMs to mimic human ventricular myocardium.
• Utilizing varying matrix stiffness to modulate tissue properties.
• Studying contractility, electrophysiology, and drug effects in the engineered cardiac tissue.

Main Results:

• The 3D cardiac tissue model successfully mimicked key features of human ventricular myocardium.
• LQT3 iPS-CMs displayed contractility malfunctions linked to their specific electrophysiological profile.
• Matrix stiffness influenced the severity of LQT3-related abnormalities and drug-induced cardiotoxicity.

Conclusions:

• The developed 3D human cardiac tissue model is a valuable tool for studying LQT3 and other cardiovascular diseases.
• This model allows for the investigation of disease-specific phenotypes and personalized drug screening.
• The findings highlight the importance of matrix microenvironment in cardiac tissue function and drug response.